Evidence map›Paper›PMID 18837863›Full record

Trial reportBipolar disorders2008

Brain lithium, N-acetyl aspartate and myo-inositol levels in older adults with bipolar disorder treated with lithium: a lithium-7 and proton magnetic resonance spectroscopy study.

Brent P Forester, Chelsea T Finn, Yosef A Berlow, Megan Wardrop, Perry F Renshaw, Constance M Moore

Open access · greenAbstract readClinical Trial
In one paragraph

Trial report in Bipolar disorders, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 2 pooled it
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 2 syntheses or guidelines pooled it, 97 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Molecular actions and clinical pharmacogenetics of lithium therapy.Pharmacology, biochemistry, and behavior · 2014
    Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Brent P ForesterGeriatric Psychiatry Research Program, McLean Hospital, Belmont, MA 02478, USA. bforester@mclean.harvard.edu
Chelsea T Finn
Yosef A Berlow
Megan Wardrop
Perry F Renshaw
Constance M Moore
McLean Hospital · USHarvard University · USImaging Center · US

Funding

PROTON MRSI STUDIES OF BIPOLAR DISORDERR01MH058681 · NIMH · UNIVERSITY OF UTAH · PI RENSHAW, PERRY FRANKLIN · 1999 to 2009
$3.0M
Magnetic Resonance Spectroscopy in Affective IllnessK01MH001978 · NIMH · MC LEAN HOSPITAL (BELMONT, MA) · PI MOORE, CONSTANCE M · 2001 to 2005
$688k
NIMH NIH HHS K01 MH001978NIMH NIH HHS MH58681NIMH NIH HHS R01 MH058681
6 · The paper itself

Abstract

objectivesWe investigated the relationship between brain lithium levels and the metabolites N-acetyl aspartate (NAA) and myo-inositol (myo-Ino) in the anterior cingulate cortex of a group of older adults with bipolar disorder (BD).

methodsThis cross-sectional assessment included nine subjects (six males and three females) with bipolar I disorder and currently treated with lithium, who were examined at McLean Hospital's Geriatric Psychiatry Research Program and Brain Imaging Center. The subjects' ages ranged from 56 to 85 years (66.0 +/- 9.7 years) and all subjects had measurements of serum and brain lithium levels. Brain lithium levels were assessed using lithium magnetic resonance spectroscopy. All subjects also had proton magnetic resonance spectroscopy to obtain measurements of NAA and myo-Ino.

resultsBrain lithium levels were associated with higher NAA levels [df = (1, 8), Beta = 12.53, t = 4.09, p < 0.005] and higher myo-Ino levels [df = (1, 7), F = 16.81, p < 0.006]. There were no significant effects of serum lithium levels on any of the metabolites.

conclusionOur findings of a relationship between higher brain lithium levels and elevated NAA levels in older adult subjects with BD may support previous evidence of lithium's neuroprotective, neurotrophic, and mitochondrial function-enhancing effects. Elevated myo-Ino related to elevated brain lithium levels may reflect increased inositol monophosphatase (IMPase) activity, which would lead to an increase in myo-Ino levels. This is the first study to demonstrate alterations in NAA and myo-Ino in a sample of older adults with BD treated with lithium.

Indexed as

Bipolar DisorderAgedAged, 80 and overAntimanic AgentsAspartic AcidBrainCross-Sectional StudiesFemaleHumansInositolLinear ModelsLithium CarbonateMagnetic Resonance ImagingMagnetic Resonance SpectroscopyMaleMiddle AgedAntimanic AgentsAspartic AcidInositolLithium CarbonateN-acetylaspartateProtons

Identifiers

PMID18837863
PMCPMC4100250
OpenAlexW2146174011

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.